FierceBiotech 9. Dez. 2025 Novartis pens $1.7B immuno-dermatology pact with AI-enabled British biotech
Endpoints News 8. Dez. 2025 #ASH25: Will a biotech’s pivot away from obesity let it compete with Novartis in leukemia?
BioPharma Dive 8. Dez. 2025 Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment
BioPharma Dive 26. Nov. 2025 Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3
Endpoints News 25. Nov. 2025 Novartis was the sole bidder in $12B deal to buy Avidity #Avidity Biosciences #buy Avidity
Endpoints News 24. Nov. 2025 #ASH25: Kelonia’s first in vivo CAR-T data; Lilly, J&J and Novartis spell out Phase 3 wins #American Society #wins Late-breaking
Lonza News 7. Okt. 2025 Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire #Therapeutic Innovations #Forecast Report
Roche Media 26. Sept. 2025 Roche, Novartis underline U.S. plans after Trump pharma tariff announcement - Reuters #Novartis underline #Trump pharma